Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
BACKGROUND: The antithrombotic efficacy of aspirin is attributed to its inhibition of the enzyme prostaglandin G/H synthase, which is necessary for the formation of thromboxane A2 in platelets. Thromboxane A2 is a potent vasoconstrictor and platelet agonist. However, the formation of prostacyclin by...
主要な著者: | Clarke, R, Mayo, G, Price, P, FitzGerald, G |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1991
|
類似資料
-
Combined administration of aspirin and a specific thrombin inhibitor in man.
著者:: Clarke, R, 等
出版事項: (1991) -
Aspirin affects early phases of metastasis through the inhibition of COX-1-thromboxane A2 axis
著者:: Lucotti, S
出版事項: (2016) -
Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2
著者:: Lucotti, S, 等
出版事項: (2019) -
Divergent roles of prostacyclin and PGE2 in human tendinopathy.
著者:: Bergqvist, F, 等
出版事項: (2019) -
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
著者:: Parish, S, 等
出版事項: (2023)